News | February 05, 2022
IOL Chemicals and Pharmaceuticals Q3FY22 PAT at Rs. 40.07 crore
IOL Chemicals and Pharmaceuticals has reported standalone financial results for the period ended December 31, 2021
IOL Chemicals and Pharmaceuticals has reported standalone financial results for the period ended December 31, 2021
Dishman Carbogen Amcis has reported consolidated financial results for the period ended December 31, 2021
Corbevax is administered through an intramuscular route with two doses scheduled 28 days apart and is stored between 2 degrees celsius to 8 degrees celsius
The company has reported standalone financial results for the period ended December 31, 2021.
Lupin has reported consolidated financial results for the period ended December 31, 2021
Sun Pharma’s Q3FY22 operational performance was in line with I-direct estimates with sustained momentum and good growth across businesses
New instrument helps maximize lab productivity and extends FTIR to large, heavy samples
Fast, flexible space allows clinical trials to start when needed. A trial can become operational, pivot or scale without traditional capital building expenditures
The target demographic will be those between the ages of 30 and 65 years
The objective behind introducing this extraordinary digital campaign is to spread awareness among Gen X and Z for the need of breast self-examination
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
